This test is most useful if any of these apply to you.
If you take an NAD booster or wonder how well your cells actually make energy, this is one of the few readings that looks directly at the energy-carrying side of that system. It captures a molecule your cells constantly recycle to turn food into fuel.
This is a research-stage marker with no settled normal range, so a single number will not diagnose anything on its own. Its value is giving you a baseline in a system that standard metabolic panels never touch, so you have your own data to compare against over time.
NADH (the reduced form of nicotinamide adenine dinucleotide) is a small molecule, not a protein, enzyme, or hormone. Nearly every cell makes it while breaking down food, through the same core pathways that release energy from sugar and fat.
Its main job is to shuttle electrons into the mitochondria, the energy-producing compartments inside your cells, where those electrons help generate the cell's fuel. NADH is the partner of a related molecule called NAD+, and the balance between them (the NAD+/NADH ratio) acts as a control switch across hundreds of reactions. This test measures the concentration of NADH in your blood.
When mitochondria cannot pass electrons along fast enough, NADH backs up inside the cell. Researchers call this state reductive stress, and it is the opposite of the more familiar oxidative stress. In one study of Leigh syndrome, a severe mitochondrial disorder, cells taken from patients had significantly higher NADH than cells from healthy people, even though their NAD+ was unchanged (this was measured in skin cells, not blood).
In another mitochondrial disease called MELAS, a validated panel of circulating markers in about 100 patients compared with 32 healthy people tracked closely with disease severity. Nearly all of those markers trace back to an elevated NADH-to-NAD+ ratio. These studies measured downstream metabolites in plasma rather than blood NADH itself, so they describe the reductive-stress state that NADH reflects rather than this exact test.
Some plasma studies of healthy aging report that NAD+ tends to fall with age while the reduced forms, NADH and a cousin molecule NADPH, tend to rise. That is one of the few findings measured in plasma, the closest match to a blood test for NADH. The picture is not settled, though: a larger study of 205 adults found no consistent age-related change in plasma NAD or the NAD+/NADH ratio. Treat the aging link as a hypothesis rather than an established pattern.
A community study of 1,394 adults found that higher whole-blood NAD levels were associated with metabolic disease and its individual components, a reminder that shifts in this system are not automatically good (this study measured total NAD, not NADH specifically). In a separate study of 54 middle-aged adults, skeletal muscle NAD, NAD+, and NADH were all lower in people coinfected with HIV, hepatitis C, and cytomegalovirus, and lower levels tracked with more inflammation and frailty (this was measured in muscle tissue, not blood).
It is tempting to assume that because NADH carries energy, more of it must be good. The evidence points the other way. A high NADH level often signals that your cells cannot offload their electrons quickly enough, which is a mark of impaired mitochondrial function, not abundant energy. This is not a simple good-number, bad-number marker. It is a balance indicator: what matters is the NAD+/NADH ratio and the direction it moves, so the same reading can mean different things depending on your NAD+ level and clinical picture.
Because there are no standardized clinical cutpoints for NADH, a single value tells you very little in isolation. The useful signal is your own trajectory: whether the number is drifting up or down over months, and whether it moves after you change something. Get a baseline, retest in 3 to 6 months if you are making changes, then at least once a year, always using the same lab and method so the numbers are comparable.
The biggest issue with NADH is measurement variability. Pooled data across studies of the same organ show the NAD+/NADH ratio can swing by more than 90% between labs, driven largely by how samples are collected and processed. NADH is also chemically fragile and can convert into other, damaged forms, so handling before the sample reaches the analyzer matters a great deal.
A second trap is chemical specificity. Many methods, especially fluorescence-based ones, struggle to fully separate NADH from the closely related molecule NADPH, so the technique your lab uses genuinely changes the number. For all of these reasons, only compare results run by the same lab with the same method, and treat values from different platforms as if they were on different scales.
If your NADH comes back higher or lower than you expected, the first step is to repeat it with the same method rather than react to one reading. Interpret it alongside its companions on the same panel: NAD+, the NAD+/NADH ratio, NADP+, NADPH, and nicotinamide give the number context that NADH alone cannot. Pairing it with routine metabolic markers helps show whether a redox shift lines up with anything else.
A persistently elevated NADH pattern combined with unexplained fatigue, muscle, or neurological symptoms is the kind of picture that warrants a conversation with a clinician familiar with mitochondrial and metabolic medicine. A lone abnormal value with no symptoms and no supporting markers is a reason to watch the trend, not to act.
Evidence-backed interventions that affect your NADH level
NADH is best interpreted alongside these tests.
NADH is included in these pre-built panels.